To improve value in the care of patients with acute myocardial infarction (MI), payment models increasingly hold providers accountable for costs. As such, providers need tools to predict length of stay (LOS) during hospitalization and the likelihood of needing postacute care facilities after discharge for acute MI patients. We developed models to estimate risk for prolonged LOS and postacute care for acute MI patients at time of hospital admission to facilitate coordinated care planning.
A
s alternative payment models shift reimbursement from payment for volume to payment for value, health care systems will be increasingly at risk for a greater proportion of their patients' cost of care. Most strikingly, the Centers for Medicare and Medicaid Services had initially discussed mandatory episode payment models (EPMs) for acute myocardial infarction (AMI), commonly referred to as bundled payments. 1 In these models, hospitals would be paid a fixed price for a hospital stay for an AMI and the related care 90 days after discharge, adjusted for performance on specific quality metrics. 2 Importantly, these costs include those incurred with other providers, such as postacute care. Although mandatory EPMs were later canceled, the Centers for Medicare and Medicaid Services is starting voluntary EPMs on October 1, 2018, called Bundled Payments for Care Improvement Advanced (BPCI Advanced), which will include AMI. 3 Given this imminent start of BPCI Advanced, there is an urgent need to develop tools to support implementation of EPMs for health care systems. These EPMs represent a dramatic shift in the way that hospitals receive payment for AMI care as compared with traditional feefor-service payment. Conceptually, EPMs represent an effort to incentivize value in cardiology, 4 with the hope that they will improve the quality of care during the index hospitalization and encourage better care transitions and postdischarge monitoring, thus reducing the total cost of care. 5 For these models to improve value, hospitals and clinicians need to be able to quickly identify patients who are at higher (or lower) risk of prolonged hospitalization and referral to postacute services after discharge. 6 Identifying high-risk patients early during hospitalization can theoretically support a fast track discharge program that avoids critical care admissions and accelerates education and health transitions for low-risk patients while enabling better communication with postacute care facilities for patients at high risk for prolonged length of stay (LOS) and needing skilled nursing care after discharge. To address these evolving changes in healthcare and to provide tools to help providers succeed in AMI alternative payment models, we sought to develop predictive models that estimate a patient's likelihood of prolonged hospitalization and need for postacute services from data available at the beginning of the index hospitalization.
METHODS
Per policy of the National Cardiovascular Data Registry, the data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results of this analysis. Nevertheless, if requested, the authors will provide samples of the analysis to assist other, future research efforts. Furthermore, requests for additional analysis with these data can be made through https://cvquality.acc. org/NCDR-Home/research/submit-a-proposal.
Study Population
The ACTION registry (Acute Coronary Treatment and Intervention Outcomes Network) is a US multicenter registry of patients hospitalized with either ST-segment-elevation MI (STEMI) and non-ST-segment-elevation MI (NSTEMI), regardless of treatment strategy. 7 Administered by the American College of Cardiology as part of the National Cardiovascular Data Registry, ACTION has a rigorous data quality program consisting of (1) a data quality report, (2) a set of internal quality metrics, and (3) a yearly audit program designed to ensure completeness, consistency, and accuracy of data. 8 Participating hospitals receive quarterly quality reports. This suite of offerings can support quality assessment through benchmarking on hospital's performance with that of other hospitals throughout the United States. Specific data included in the registry are listed at https://www.ncdr.com/webncdr/ action/home/datacollection. Participating hospitals include more than a quarter of all hospitals caring for patients with AMI in the United States. 9 Patients in ACTION who were discharged alive from July 1, 2008 and March 31, 2017, were eligible for analysis. We excluded patients discharged to hospice care, those transferred to a different acute care facility, and patients who were discharged from the hospital against medical advice. We also excluded patients with data collected on the limited data collection form in ACTION, given lack of needed data elements. Numbers of excluded and included patients are shown in Figure 1 .
Analyses from ACTION were approved by Chesapeake Research Review, Inc, an independent institutional review board, and conducted by the National Cardiovascular Data Registry analytic center at Saint Luke's Mid America Heart Institute.
Outcomes and Covariates
We aimed to create predictive models for 2 clinical outcomes: LOS and discharge to a postacute facility. LOS was defined as
WHAT IS KNOWN
• Voluntary episode payment models (bundled payments) within Medicare are going to begin soon.
• Cardiology episodes of care, including acute myocardial infarction, are prominent within the new payment models.
• For these models to improve value, clinicians need to be able to quickly identify patients who are likely to require more intense utilization, including prolonged length of stay and postacute care after discharge.
WHAT THE STUDY ADDS
• The models presented here can prospectively predict both length of stay and postacute utilization for acute myocardial infarction patients at the time of initial hospitalization.
• Integrating these models into clinical practice might lead to clinical innovations that improve quality and value.
an ordinal variable by subtracting discharge date from admission date and rounding to the nearest whole number. We defined a short LOS as 0 to 2 days, an intermediate LOS as 3 to 6 days, and a prolonged LOS as ≥7 days. We chose these categories simply to describe the distribution of characteristics of AMI hospitalizations in different LOS ranges, although the ordinal model allows for predicting hospitalization within any specific LOS threshold. Discharge to postacute facility was defined as any discharge to extended care, a transitional care unit, or rehabilitation. Initially, we examined all available variables and their distributions related to medical history, presentation, clinical status at admission, and demographics. Candidate variables for the prediction models were selected based on clinical relevance 10 and had to be available to clinicians at admission, as the goal was to develop models that could be used at time of initial hospitalization. Given this clinical purpose, we did not consider predictor variables not known to clinicians on admission. Considered variables included age, sex, body mass index, selftransport (yes/no), race (white, black, Asian, American Indian or Alaskan Native, and Native Hawaiian or Pacific Islander), insurance status (Medicare, Medicaid, no insurance, or private insurance), heart failure at first medical contact (yes/no), cardiogenic shock at first medical contact (yes/no), systolic blood pressure (SBP) at first medical contact (mm Hg), pulse at first medical contact (beats/min), STEMI (versus NSTEMI), smoking (yes/no), hypertension (yes/no), dyslipidemia (yes/no), end-stage renal failure requiring dialysis (yes/no), diabetes mellitus (yes/no), glomerular filtration rate (mL/min), hemoglobin (g/dL), prior heart failure (yes/no), prior MI (yes/no), prior percutaneous coronary intervention (yes/no), prior coronary artery bypass surgery (yes/ no), prior atrial fibrillation (yes/no), prior cerebrovascular disease (yes/no), and prior peripheral arterial disease (yes/no).
Statistical Analysis
Demographic and clinical characteristics were compared among patients in the 3 LOS categories using 1-way ANOVA for continuous variables and χ 2 tests for categorical variables. Demographic and clinical characteristics were compared between those who did versus did have require postacute care using independent t tests for continuous variables and χ 2 tests for categorical variables. For the LOS model (with a continuous outcome), we used a cumulative proportional logit model, which predicts the likelihood of a LOS for each distinct number of days. This approach is appropriate for continuous data 11 and clinically useful because it allows modeling of short versus long LOS, as well as produces a predicted mean LOS for each patient. Nevertheless, we explored the implications of this statistical approach in a sensitivity analysis described below. For the postacute model (with a binary outcome), we used logistic regression. We used split-sample methods for training and internal validation, with the models derived in a 70% random sample of the data and then internally validated in the remaining 30% of data. Although the split proportion is arbitrary, other National Cardiovascular Data Registry risk models have used 70/30 12, 13 and 80/20 splits. 14 Because our intent was to create parsimonious models useful to clinicians for bundled payments, we used backward selection procedures according to the method of Harrell. 15 In this approach, the total adjusted variability (R 2 ) of an initial model considering all candidate variables is first estimated. Then, sequential backwards elimination is performed, with estimation of total model adjusted R 2 at each step. When the adjusted R 2 falls <90% of the R 2 of the initial model, the selection procedure is terminated, and the remaining variables are retained in the final model. Both models were hierarchical, with hospitallevel random effects to account for clustering of patients within specific hospitals and to minimize the influence of local practice variation on patient-level predictors of the 2 outcome variables. Cubic splines were considered for all continuous variables. Missing data were minimal for all variables (<0.5%) and was addressed by imputation with sequential regression using the IVEWare software (Ann Arbor, MI). No patients were excluded because of missing data.
To facilitate the utility of the risk models for clinicians at the bedside, as well as for automated decision support tools embedded within electronic health records, we created simplified risk scores for both prediction models. 16 We then validated the 2 reduced models in the Validation cohort. Model discrimination was assessed via the C statistic, 17 and calibration was assessed by plotting observed versus predicted rates of the 2 outcomes in the Validation cohort. Model performance was also tested separately among patients admitted with STEMI and NSTEMI. In both models, collinearity was assessed with variance inflation factors. To test potential influence of our variable selection methodology and candidate variables on our results, we conducted sensitivity analyses using a forward selection procedure and forcing history of cancer and history of chronic lung disease into the models.
To assess the effect of secular trends, we included year as a predictive variable in both models as an additional sensitivity analysis. To assess the effect of a cumulative proportional logit model (ie, treating the LOS data as ordinal data), we also conducted a sensitivity analysis with a negative binomial distribution (treating the LOS data as count data). Because results of all these sensitivity analyses were substantively unchanged, they are presented in the Appendix in the Data Supplement. All statistical analyses were performed using SAS Version 9.2.
RESULTS

Study Population
Among 1 247 251 patients who were admitted with a STEMI or NSTEMI to an ACTION participating hospital between July 1, 2008 and March 31, 2017, we excluded 237 987 (19.1%) because the hospitals used the short form, 43 172 (3.5%) because they died during hospitalization, 45 410 (3.6%) because they were transferred to another acute care facility, 6772 (0.5%) because they were discharged against medical advice, and 7586 (0.6%) because they were discharged to hospice. As such, our final analytic cohort included 906 324 patients (Figure 1 Table 2 .
LOS Model Development and Validation
After multivariable adjustment and stepwise elimination, 9 variables were retained in the ordinal LOS model. Figure 2A 
Postacute Care Model Development and Validation
After multivariable adjustment and stepwise elimination, 9 variables were retained in the postacute care model. Factors independently associated with a greater odds of discharge to postacute facility included older age (OR, 2.01 per 10 years; 95% CI, 1.99-2.03), heart failure on admission (OR, 1.79; 95% CI, 1.75-1.84), higher heart rate on admission (OR, (Figure 3) . The simplified risk model for postacute care appears in Figure 4B . Patients in the low-risk cohort (points between −3 and 3) had an observed rate of postacute care of 1.6%. Patients in the intermediate risk cohort (points between 4 and 9) had an observed rate of postacute care of 11.2%. Patients in the high-risk cohort (points ≥10) had an observed rate of postacute care of 27.4%.
DISCUSSION
As health care reimbursement increasingly shifts from volume to value based, hospitals will be at increasing financial risk to manage patients more efficiently. In this work, we sought to build tools for clinicians and health systems to predict risks of patients for prolonged LOS and need for postacute care. In doing so, we have demonstrated that with clinical characteristics known at the time of initial hospitalization for AMI, both LOS and postacute utilization can be predicted with moderate and strong predictive accuracy, respectively. With implementation of episode-based payment in October 2018, which is intended to incentivize reduction in costs, these risk models will be essential for identifying higher-(or lower-) risk patients for whom interventions may be implemented. Furthermore, by facilitating the ability of clinicians to respond to changing payment models in ways that improve targeting resources to patients at higher risk of incurring unnecessary costs, these models can improve the likelihood that payment reforms will improve value in AMI care.
For a model to be actionable, the patient risk must be known as soon as possible, so care pathways can be implemented to streamline care needs. We thought there would be great clinical utility in knowing, on the day of admission, if a patient was likely to be able to be discharged within a short time frame. For example, knowing at the time of admission that a patient is likely to have a short LOS, it might be possible to redesign care pathways and hospital spaces that avoid intensive care unit stays for these patients and prevent the time, workload and delays of interunit transfers within a hospital. Furthermore, patients with expected short LOS could have early coordination with family and potentially early referral to cardiac rehabilitation. Conversely, knowing the projected LOS for a sicker patient and the likelihood that they would need postacute care after discharge could enable earlier discussions with specific skilled nursing facilities to enable a smoother transition in care. Although we established thresholds to define short and prolonged LOS to describe our data, our model considers LOS as an ordinal variable, so this model allows any thresholds to be defined by health delivery systems and specific clinicians.
Previous work has identified predictors of both postacute care and prolonged LOS in other procedures and disease conditions. After joint replacement, a model including age, sex, race, disability, dual eligibility for Medicare and Medicaid, LOS, intensive care unit use, number of acute hospitalizations in the past year, catheter-associated urinary tract infection, and venous thromboembolism predicted postacute care with moderate discrimination (C statistic=0.66).
18 Importantly, this model included several factors present during the hospitalization (eg, LOS, intensive care, complications) that render its ability to impact care much lower. In a general medical population, a model including 5 functional status variables (patient's partner inability to provide home help, inability to self-manage drug regimen, number of active medical problems on admission, dependency in bathing, and in transfers from bed to chair) predicted discharge to postacute care with strong predictive ability (C statistic=0.82). 19 Unfortunately, we were unable to include some functional status or frailty measures in our models, which could have improved model performance even further. Frailty is known to be associated with poor prognosis in patients with AMI, 20 so markers of frailty, such as serum albumin may have been useful in risk prediction. Hemoglobin was considered, retained in the selection procedures, and included in both final models. Furthermore, integrating these clinical registry data with administrative data, such as the Johns Hopkins Ambulatory Care Group measure 21 or the inpatient Charlson-Deyo 22 or Elixhauser measures 23 may further improve model discrimination. Furthermore, because prior studies suggest that prediction of postacute care may depend on different variables for different disease conditions and procedures. For example, variables found to be influential in our models, such as shock and heart failure on presentation are unlikely to be influential in predicting postacute care after elective procedures such as joint replacement. Our postacute model combines predictor variables that may be specific to AMI (heart failure, heart rate, and shock at first contact) with predictor variables associated with postacute care in other settings (age, hemoglobin, and insurance status). We are reassured that the collinearity of these AMI-specific and non-AMI specific predictors is low, strengthening our confidence in the estimates identified in the model. Among these 2 models, discrimination is stronger for predicting postacute care than LOS. Although some clinical outcomes, such as mortality, are straightforward to predict, others are not, including LOS and readmission. In this specific case, potential variability in patients' LOS is likely influenced by many nonpatientrelated factors, including poor communication among providers or between providers and caregivers on when a patient is ready for discharge, interphysician variability in the assessment of when a patient is safe to be discharged, pretreatment with thienopyridines in NSTEMI patients who are then found to require coronary artery bypass surgery, poor anticoagulation management, or the use of excessive contrast such that patients develop acute renal injury all may diminish the predictive accuracy of the model. Thus, although the model's discrimination is comparable to other routinely used models such as readmission models, we think that its lower discrimination underscores the opportunity to reduce variability and inefficiency in AMI care and to improve the value of treatment. Moreover, we hope that widespread use of this LOS model could enable the development of novel protocols that could decrease unwarranted variations in care, ultimately leading to better performing LOS models over time. We did not include year as a candidate variable, given that the intent was to develop models useful to clinicians, but because the incidence and prognosis of AMI have been changing over time, 24 the models' discrimination should be reassessed in the future. We are reassured that including year as a predictive variable in sensitivity analysis did not change the discrimination of the models.
We think that these models may substantially improve the ability of health care providers and health delivery organizations to improve performance in EPMs and other types of payment mechanisms that incentivize judicious use of resources and costs, although further research into how best to use these models is needed. Developing risk-based protocols, implementing the tools and evaluating their impact on care, outcomes and costs are an important direction for future research. In addition to BPCI Advanced, many similar incentives exist for providers to reduce unnecessary health care expenditures. Cardiologists increasingly are delivering care within accountable care organizations, both within Medicare and with private insurers, which offer shared savings to providers if costs do not exceed specific benchmarks. 25 Although we think these models will be the most useful to hospitals seeking to improve the efficiency of their care, we also recognize that these models could be used to risk adjust for patient complexity. On one hand, risk adjustment in pay for performance models may limit provider avoidance of higher-risk patients, a potential adverse consequence of pay for performance. 26 However, risk adjustment can also actually create unintended incentives and threaten the validity of quality metrics. For example, although the Hospital Readmissions Reduction Program was associated with lower risk standardized and absolute readmission rates, [27] [28] [29] much of the improvement in risk-adjusted readmission rates was related to increased reporting of comorbidities. 30 Perhaps because of those concerns, BPCI Advanced does not currently use risk adjustment B Figure 4 Continued. B, Simplified risk score for predicting postacute care. CVD indicates cerebrovascular disease; DM, diabetes mellitus; HF, heart failure; HGB, hemoglobin; HR, heart rate; and SBP, systolic blood pressure.
for AMI EPMs. 3 In the specific case of our models presented here, the outcome predicted is a blend of a clinical outcome and a clinical decision. For example, LOS and utilization of postacute care after discharge are influenced both by clinical circumstances and provider decisions. Conceptually, therefore, using these metrics for public reporting or payment adjustment, without valid risk adjustment, could create misplaced incentives to avoid postacute care when patients need it or reducing LOS inappropriately. Because the detailed clinical data used in these models are not available in administrative databases, we think our models are best used to design clinical interventions, based on patients' risks, to optimize quality and performance in EPMs rather than report or adjust payments based on the outcomes of LOS or postacute utilization themselves.
Our results here should be interpreted in the setting of important limitations. First, as an analysis of observational data in a clinical registry, there is always the possibility of confounding with unmeasured variables associated with both predictors and the outcome variables. Second, the elements we selected were constrained to those collected in ACTION, and other important predictors of these outcomes (eg, frailty) will need to be tested in future research studies. Markers of frailty, including serum albumin and serum hemoglobin levels, might improve the discrimination of these models. Third, because these data are derived from a voluntary registry, the external validity of our findings to all hospitals is uncertain. In particular, hospitals more interested in quality improvement may be more likely to participate in the registry. We are reassured, however, by our large sample size of patients with AMI throughout the United States. Finally, our model cannot account for events that occur during the course of AMI hospitalization. Adding such information might improve the discrimination of the models. We did not consider clinical events during hospitalization for the models, however, because we viewed the clinical utility of the models as guiding interventions to specific patients at time of initial hospitalization.
CONCLUSIONS
We demonstrate here that for AMI patients with variables known at the time of initial admission, prolonged LOS can be predicted with moderate discrimination and that need for postacute care can be predicted with strong discrimination. These models can be used at the bedside by providers both to improve the quality of care and improve performance in alternative payment models, such as bundled payments, although further development of risk-based protocols and the impact of implementing these models require more study.
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